The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A

M Scannell1, E Burton1, P M Kearney1

  • 1School of Public Health, University College Cork, Cork, Ireland.

PubMed

Insights

Prior approval for direct oral anticoagulants (DOACs) in Ireland had minimal impact on prescribing trends. Removing this cost containment policy did not significantly alter the overall use of oral anticoagulants.

Area of Science:

  • Health Economics
  • Pharmacoeconomics
  • Public Health Policy

Background:

  • Prior approval for medication reimbursement is a cost containment strategy.
  • Ireland implemented prior approval for direct oral anticoagulants (DOACs) due to financial pressures from the shift from warfarin.
  • Limited studies exist on the effectiveness of prior approval policies for DOACs.

Purpose of the Study:

  • To evaluate the effectiveness of prior approval for reimbursement of apixaban and rivaroxaban as a cost containment measure in Ireland.
  • To analyze the impact of prior approval policies on the prescribing patterns of oral anticoagulants.

Main Methods:

  • Cross-sectional study using the Irish Health Service Executive-Primary Care Reimbursement Service database (2018-2021).
  • Analysis of prescribing frequencies and costs of oral anticoagulants (apixaban, rivaroxaban, warfarin).
  • Time series negative binomial regression to assess the impact of removing prior approval requirements.

Main Results:

  • Overall oral anticoagulant prescribing frequency increased by nearly 20% between 2018 and 2021.
  • Significant variations in oral anticoagulant prescribing proportions were observed across Community Drug Schemes.
  • A statistically significant decrease in apixaban use (<1%) was noted after prior approval removal.

Conclusions:

  • Removal of prior approval for DOAC reimbursement in Ireland had a minimal effect on overall oral anticoagulant prescribing trends.
  • Healthcare systems should carefully consider drug type, approval criteria, and policy duration when implementing prior approval policies.
  • Minimizing negative effects associated with prior approval policies requires careful planning and evaluation.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3